Improving the Sensitivity of a Novel PIM Kinase-Targeted Therapeutic Agent, CXR1002, Through Identification and Modulation of Cross-Talking Pathways (PhD Studentship)

  • Meek, David (Investigator)

    Project Details

    StatusFinished
    Effective start/end date1/09/12 → 1/09/16